Japan to scrap rule requiring testing of new drugs on Japanese (asia.nikkei.com)

submitted 1 year ago by stopthatgirl7@kbin.social to c/worldnews@lemmy.ml

8 comments fedilink hide all child comments

Dropping slow process in early clinical trials would make medicines available sooner

you are viewing a single comment's thread
view the rest of the comments

[-] bandario@lemmy.dbzer0.com 10 points 1 year ago

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2976712/

It's significant. Biggest effect is on efficacy of drug metabolism. There are many such studies.

One size does not fit all here owing to differences in expression of metabolising enzymes and drug transport mechanisms.

No, the Japanese are not aliens but they may require far less of a given drug than a westerner, or far more. This affects the likelihood to experience side effects for any given compound, and their severity.

It's fairly ironic to make this change for Japan whilst elsewhere in the world with more racially mixed populations there has been a push in the opposite direction: a recognition that you cannot assume the results of a trial carried out on white male subjects will apply to those of African descent for example.

It's not just drug treatments either. There are many aspects of medical care which have suffered from a lack of specificity and systemic bias.

[-] regul@lemm.ee 2 points 1 year ago

Wouldn't Japan have decades of data to analyze, though? Comparison of the global vs Japanese trials, any detected differences once released, etc. It's not like they're making this decision blind.